Medtronic lands U.S., U.K. wins for next-gen cool ablation balloon

Fri, 08/24/2012 - 12:22pm
Mass Device

Medical device giant Medtronic wins marketing clearance for its 2nd generation Arctic Front cryoablation balloon system with uniform cooling technology.

Medtronic Arctic Force cryoablation balloon

Medtronic's (NYSE:MDT) expects its newly cleared 2nd generation Arctic Front cryoballoon system to storm clinics in the U.S. and Europe.

The device, indicated for treating an irregular heartbeat, won FDA clearance as well as CE Mark approval in the European Union, the medical device giant announced today.

If it's predecessor was any indication, the device could see rapid adoption among clinicians worldwide.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.